A view from the Center

>

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

What would a future with longer health span mean for end of life?

by Claire Cruse, Health Policy Manager, Deloitte Center for Health Solutions, Deloitte Services LP

It’s not a topic that most of us enjoy thinking or talking about. But it’s a reality I faced at the age of 13 and will face again in July—the 20th anniversary of my mother’s death. It’s something that we all must acknowledge at some point in our lives: None of us will be around forever.

Read more

Can the world’s biggest companies save health care?

by Margaret Anderson, Managing Director, Deloitte Consulting LLP

It’s no secret that we often don’t get what we pay for when it comes to health care. While we spend upwards of $3.5 trillion a year for health care in the US1, our longevity, infant and child mortality, and maternal mortality fall behind other countries.2 Eric Topol, author of the book Deep Medicine,

Read more

The Future of Health: You need to believe it to see it

by Neal Batra, Principal, Deloitte Consulting LLP

Over the past several months, my colleagues and I have been detailing Deloitte’s vision for the future of health to our health and life sciences clients. In meetings and presentations, we describe a landscape that looks vastly different from what we have today. Some of our clients are understandably skeptical—especially considering some of the dramatic changes we anticipate.

Read more

Before moving data to the cloud, health organizations should assess benefits and risks

by Jeffrey Winn and Justin Rowe, Cyber Risk Services, Deloitte & Touche LLP

A growing number of health care organizations expect to move their electronic health records (EHRs) to the cloud.1 Migrating EHRs and other data to the cloud could make it easier for these organizations to build and use next-generation solutions such as big data analytics, population health, digital health, and use of the internet of things (IoT) to keep pace with future trends.

Read more

The future of health could be ‘udderly’ amazing

by Steve Davis, Deloitte Center for Health Solutions

When it comes to the future of health, it seems that cows (yes, cows!) might be a couple hoof-steps ahead of people. While visiting relatives in Ireland last month, we stopped at a small dairy farm about 90 miles outside of Belfast. What I saw in the barn that afternoon lines up surprisingly well with Deloitte’s vision for the future of health where always-on sensors detect potential health problems long before symptoms surface.

Read more

With drug rebates on the chopping block, stakeholders should prepare for change

by George Van Antwerp, Managing Director, Deloitte Consulting LLP

Early this year, the US Department of Health and Human Services (HHS) proposed eliminating safe-harbor protections for the rebates drug manufacturers pay to pharmacy benefit managers (PBMs), Medicare Part D plans, and Medicaid managed care organizations. At the same time, HHS proposed two new safe-harbor protections for some point-of-sale (POS) price reductions on prescription drugs and certain PBM service fees.

Read more